In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Francesco Cosentino
Speaker
Francesco Cosentino
Francesco Cosentino Francesco Cosentino

Karolinska University Hospital, Stockholm (Sweden)

Speciality : Coronary Artery Disease Chronic

25 presentations from this speaker

Diabetes: new therapeutic strategies, glucose and risk factor control.

Event : Webinar 2020

  • Session : EAPC Webinars 2020
  • Speaker : F Cosentino (Stockholm,SE), L Mellbin (Bromma,SE), L Ryden (Stockholm,SE)

VERTIS CV Heart Failure Results

Event : ESC Congress 2020

  • Session : Late-Breaking Science in Diabetes and the Heart
  • Speaker : F Cosentino (Stockholm,SE)

Challenge the experts: panel and audience discussion

Event : ESC Congress 2019

  • Session : Impact of novel guidelines: transforming diabetes management in cardiology
  • Speaker : F Krag Knop (Copenhagen,DK), J Deanfield (,GB), F Cosentino (Stockholm,SE), N Marx (Aachen,DE)
  • Organised by PACE-CME, supported with an educational grant provided by Novo Nordisk

Discussion

Event : ESC Congress 2019

  • Session : Transforming diabetes management in cardiology: impact of novel therapies
  • Speaker : F Cosentino (Stockholm,SE)
  • Organised by PACE-CME, supported with an educational grant provided by Novo Nordisk

Guidelines on diabetes, pre-diabetes and cardiovascular diseases in a nutshell

Event : ESC Congress 2019

  • Session : Impact of novel guidelines: transforming diabetes management in cardiology
  • Speaker : F Cosentino (Stockholm,SE)
  • Organised by PACE-CME, supported with an educational grant provided by Novo Nordisk

Interactive panel discussion

Event : ESC Congress 2019

  • Session : Rewriting the textbooks: SGLT2 inhibitors and cardiovascular disease in type 2 diabetes
  • Speaker : F Cosentino (Stockholm,SE), M Cowie (London,GB), O Schnell (Neuherberg,DE)
  • Sponsored by the Mundipharma network of independent associated companies

Introduction

Event : ESC Congress 2019

  • Session : Transforming diabetes management in cardiology: impact of novel therapies
  • Speaker : F Cosentino (Stockholm,SE)
  • Organised by PACE-CME, supported with an educational grant provided by Novo Nordisk

Pathophysiologic aspects on diabetes related macro- and microvascular complications.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2019

  • Session : Masterclass on Diabetes & CV Risk Part 1: The patient with diabetes
  • Speaker : F Cosentino (Stockholm,SE)

SGLT-2 inhibitors and cardiac metabolism.

Event : Heart Failure 2019

  • Session : Diabetes and heart failure
  • Speaker : F Cosentino (Stockholm,SE)

Welcome and objectives.

Event : ESC Congress 2019

  • Session : Rewriting the textbooks: SGLT2 inhibitors and cardiovascular disease in type 2 diabetes
  • Speaker : F Cosentino (Stockholm,SE)
  • Sponsored by the Mundipharma network of independent associated companies

What is new in 2019 Guidelines on Diabetes, Pre-diabetes and Cardiovascular Diseases

Event : ESC Congress 2019

  • Session : 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD)
  • Speaker : F Cosentino (Stockholm,SE)

Discussion - Targeting SGLT2 in clinical cardiology: exploring the benefits in cardiovascular risk, diabetes & heart failure.

Event : ESC Congress 2018

  • Session : Targeting SGLT2 in clinical cardiology: exploring the benefits in cardiovascular risk, diabetes & heart failure (EBAC Accredited)
  • Speaker : F Cosentino (Stockholm,SE)
  • Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim/Lilly

Epigenetic signatures and cardiovascular risk in diabetes.

Event : ESC Congress 2018

  • Session : How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?
  • Speaker : F Cosentino (Stockholm,SE)
  • Joint with the European Association for the Study of Diabetes

Introduction - Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure.

Event : ESC Congress 2018

  • Session : Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure
  • Speaker : F Cosentino (Stockholm,SE)
  • Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim/Lilly

Introduction - Targeting SGLT2 in clinical cardiology: exploring the benefits in cardiovascular risk, diabetes & heart failure.

Event : ESC Congress 2018

  • Session : Targeting SGLT2 in clinical cardiology: exploring the benefits in cardiovascular risk, diabetes & heart failure (EBAC Accredited)
  • Speaker : F Cosentino (Stockholm,SE)
  • Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim/Lilly

Panel discussion: discussing the benefits in cardiovascular risk, diabetes & heart failure.

Event : ESC Congress 2018

  • Session : Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure
  • Speaker : S Jacob (Villingen,DE), J Deanfield (,GB), N Marx (Aachen,DE), F Cosentino (Stockholm,SE)
  • Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim/Lilly

Diabetic cardiomyopathy.

Event : Heart Failure 2016

  • Session : Cardiomyopathies: what are the mechanisms?
  • Speaker : F Cosentino (Stockholm,SE)

Redox changes in vascular ageing

Event : ESC Congress 2016

  • Session : Cardiac biology and senescence
  • Speaker : F Cosentino (Stockholm,SE)
  • Joint with the Japanese Circulation Society (JCS)

Hyperglycemic memory in the heart and vessels.

Event : Heart Failure 2015

  • Session : Diabetes and heart failure: double jeopardy
  • Speaker : F Cosentino (Stockholm,SE)

Molecular mechanisms of vascular dysfunction in Type 2 diabetes.

Event : ESC Congress 2015

  • Session : Mechanisms of thrombosis.
  • Speaker : F Cosentino (Stockholm,SE)
  • ESC and the European Association for the Study of Diabetes

Optimal medical treatment, stenting or grafting? Who gets what? Case presentation.

Event : ESC Congress 2014

  • Session : Cardio-diabetology or diabeto-cardiology
  • Speaker : F Cosentino (Stockholm,SE)

Presentation of the awardee.

Event : ESC Congress 2014

  • Session : ESC Rene Laennec Lecture on Clinical Cardiology
  • Speaker : F Cosentino (Stockholm,SE)

Improved life-style, drugs or both - what is best for patients with impaired glucose tolerance and what is the yield?

Event : ESC Congress 2013

  • Session : New developments on prevention of diabetes: East versus West
  • Speaker : F Cosentino (Stockholm,SE)

The ESC registry on chronic ischaemic cardiovascular disease: peripheral artery disease data.

Event : ESC Congress 2013

  • Session : ESC Clinical Practice Guidelines on peripheral artery diseases: 2 years later - what the cardiologist needs to know
  • Speaker : F Cosentino (Stockholm,SE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are